AI assistant
Sending…
CUMBERLAND PHARMACEUTICALS INC — Director's Dealing 2012
May 24, 2012
34617_dirs_2012-05-24_11dfa65c-ee30-46ca-b405-1e0ec7cdfda1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK: 0001087294
Period of Report: 2012-05-22
Reporting Person: KAZIMI A J (Director, Chairman and CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-22 | Options | $14.30 | D | 30000 | Disposed | 2008-07-31 | Common stock (30000) | Direct |
| 2012-05-22 | Options | $14.30 | D | 30000 | Disposed | 2014-02-16 | Common stock (30000) | Direct |
| 2012-05-22 | Options | $12.42 | D | 50000 | Disposed | 2015-03-26 | Common stock (50000) | Direct |
| 2012-05-22 | Restricted stock | $0.00 | A | 13497 | Acquired | Common stock (13497) | Direct |
Footnotes
F1: Vested 25% per year beginning 12/31/08 - 12/31/11.
F2: Vested 25% per year beginning 12/31/09 - 12/31/12.
F3: Vested 25% per year beginning 12/31/10 - 12/31/13
F4: Restricted shares acquired in exchange for options tendered as part of the Exchange Program that ended on May 21, 2012.
F5: Restricted stock does not expire.
More from CUMBERLAND PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20